cancer Archives – Cambridge Enterprise

Caring for cancer patients

31 January 2024

Next-gen cancer therapies lands £48 million for T-Therapeutics

15 November 2023

Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion

Polyproxin® molecules

PolyProx Therapeutics: a new class of drugs to halt difficult-to-drug cancers

27 February 2020

Cambridge Enterprise joins largest-ever early stage investment in a UK university spin-out

03 October 2016

PhoreMost and The Wistar Institute collaborate to identify new druggable targets

PhoreMost raises £2.5m to identify new targets for therapeutics

Cropped shot of a male scientist conducting blood tests in a medical lab

Inivata raises £4m to improve cancer treatment through simple blood tests

23 September 2014

Rewiring stem cells aids understanding of medical conditions

09 January 2014

Breaking down pancreatic cancer defence mechanisms

20 December 2013

Sequencing: How large is the alphabet of DNA?

12 December 2013

Astex Pharmaceuticals acquired by Otsuka

11 September 2013